Collegium to Participate in Upcoming Investor Conferences

STOUGHTON, Mass., Sept. 03, 2019 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management, today announced that management will participate in the following investor conferences in September:

• The Janney Healthcare Conference 2019 on Monday, September 9th in New York City. Management will present at 8:15 a.m. ET and will also participate in investor meetings.  
• The H.C. Wainwright 21st Annual Global Investment Conference on Tuesday, September 10th in New York City. Management will present at 11:15 a.m. ET and will also participate in investor meetings.

About Collegium Pharmaceutical, Inc.

Collegium is a specialty pharmaceutical company committed to being the leader in responsible pain management. Collegium’s headquarters are located in Stoughton, Massachusetts. For more information, please visit the company’s website at www.collegiumpharma.com.

Contact: Alex Dasalla [email protected]

Source: Collegium Pharmaceutical, Inc.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Crypto News Today: AlphaPepe Presale Nears Sellout With 11,000 Buyers While XRP Price Prediction Eyes $10
• “YOU BRING CHARM TO THE WORLD - The 18th Global Chinese Awards” Concludes in Beijing
• Collegium Pharma (COLL) 2700 contracts of August 39 calls trade